Bone growth stimulators are medical devices that stimulate bone growth by providing a low-level electrical or electromagnetic field to promote healing. These devices have been around for a few decades, but recent technological advancements have led to the development of more effective and efficient appliances. As a result, the bone growth stimulator market has witnessed significant growth in recent years, which is expected to continue.
The global market is expected to grow at a CAGR of 12.8% from 2023 to 2032. The growing prevalence of bone-related disorders, such as osteoporosis, is a key factor driving this market's growth.
The market for bone growth stimulators can be broadly segmented into two categories:
External bone growth stimulators are non-invasive devices worn outside the body and used to treat bone fractures and spinal injuries. External bone growth stimulators currently dominate the market, accounting for over 80% of the market share.
On the other hand, implantable bone growth stimulators are surgically implanted devices that promote bone growth after spinal fusion surgeries or other orthopedic procedures. However, implanted bone growth stimulators are expected to grow significantly in the coming years due to their higher efficacy and convenience.
Region Dominating the industry:
North America is the largest market for bone growth stimulators, accounting for more than 40% of the total market share. The region's dominance can be attributed to a large patient population, favorable reimbursement policies, and the availability of advanced healthcare infrastructure. The Asia Pacific region is expected to witness the highest growth rate during the forecast period, owing to the rising prevalence of bone-related disorders, increasing healthcare expenditure, and growing awareness about the benefits of bone growth stimulators.
Key Players of the Market:
Key players operating in the bone growth stimulator market include MEDTRONIC PLC., DJO Global, STRYKER CORPORATION, JOHNSON and JOHNSON, Essex Woodlands Healthcare Partners (Bioventus LLC), Isto Biologics, etc. These companies focus on product innovation and development to stay ahead in the market.
Conclusion:
The bone growth stimulator market is experiencing robust growth and is expected to grow in the coming years. The increasing prevalence of bone-related disorders, the growing geriatric population, and the adoption of non-invasive treatment options are the key drivers of this growth. As technology continues to advance, we can expect to see more innovative and efficient bone growth stimulators enter the market, further driving growth in the years to come.
Deep-dive Insights on Bone Growth Stimulator Market by Polaris Market Research: https://www.polarismarketresearch.com/industry-analysis/bone-growth-stimulator-market/request-for-sample